BlackRock’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
434,768
-47,314
| -10% | -$137K | ﹤0.01% | 4109 |
|
|
2025
Q1 | $347K | Sell |
482,082
-3,270
| -0.7% | -$2.35K | ﹤0.01% | 4437 |
|
|
2024
Q4 | $500K | Buy |
485,352
+532
| +0.1% | +$548 | ﹤0.01% | 4360 |
|
|
2024
Q3 | $650K | Buy |
484,820
+1,418
| +0.3% | +$1.9K | ﹤0.01% | 4216 |
|
|
2024
Q2 | $628K | Buy |
483,402
+6,506
| +1% | +$8.46K | ﹤0.01% | 4233 |
|
|
2024
Q1 | $820K | Sell |
476,896
-3,703
| -0.8% | -$6.37K | ﹤0.01% | 4193 |
|
|
2023
Q4 | $706K | Sell |
480,599
-1,210
| -0.3% | -$1.78K | ﹤0.01% | 4268 |
|
|
2023
Q3 | $583K | Sell |
481,809
-41,995
| -8% | -$50.8K | ﹤0.01% | 4318 |
|
|
2023
Q2 | $760K | Buy |
523,804
+33,991
| +7% | +$49.3K | ﹤0.01% | 4278 |
|
|
2023
Q1 | $710K | Buy |
489,813
+1,730
| +0.4% | +$2.51K | ﹤0.01% | 4363 |
|
|
2022
Q4 | $844K | Sell |
488,083
-204,055
| -29% | -$353K | ﹤0.01% | 4375 |
|
|
2022
Q3 | $1.39M | Buy |
692,138
+1,385
| +0.2% | +$2.77K | ﹤0.01% | 4270 |
|
|
2022
Q2 | $513K | Sell |
690,753
-1,103,328
| -61% | -$819K | ﹤0.01% | 4678 |
|
|
2022
Q1 | $15.6M | Sell |
1,794,081
-4,696
| -0.3% | -$40.9K | ﹤0.01% | 3254 |
|
|
2021
Q4 | $28.8M | Sell |
1,798,777
-3,751
| -0.2% | -$60.1K | ﹤0.01% | 2984 |
|
|
2021
Q3 | $33.2M | Buy |
1,802,528
+23,706
| +1% | +$436K | ﹤0.01% | 2892 |
|
|
2021
Q2 | $24.8M | Buy |
1,778,822
+2,226
| +0.1% | +$31.1K | ﹤0.01% | 3115 |
|
|
2021
Q1 | $26.2M | Buy |
1,776,596
+44,996
| +3% | +$662K | ﹤0.01% | 2988 |
|
|
2020
Q4 | $33.6M | Buy |
1,731,600
+654,438
| +61% | +$12.7M | ﹤0.01% | 2667 |
|
|
2020
Q3 | $12M | Buy |
1,077,162
+126,906
| +13% | +$1.42M | ﹤0.01% | 3047 |
|
|
2020
Q2 | $12.9M | Buy |
950,256
+69,025
| +8% | +$934K | ﹤0.01% | 2985 |
|
|
2020
Q1 | $7.12M | Buy |
881,231
+125,966
| +17% | +$1.02M | ﹤0.01% | 3119 |
|
|
2019
Q4 | $7.26M | Buy |
755,265
+76,316
| +11% | +$734K | ﹤0.01% | 3348 |
|
|
2019
Q3 | $7.2M | Buy |
678,949
+22,171
| +3% | +$235K | ﹤0.01% | 3330 |
|
|
2019
Q2 | $7.56M | Buy |
656,778
+235,691
| +56% | +$2.71M | ﹤0.01% | 3337 |
|
|
2019
Q1 | $5.4M | Buy |
421,087
+27,457
| +7% | +$352K | ﹤0.01% | 3346 |
|
|
2018
Q4 | $2.42M | Buy |
393,630
+21,161
| +6% | +$130K | ﹤0.01% | 3579 |
|
|
2018
Q3 | $3.92M | Buy |
372,469
+30,470
| +9% | +$320K | ﹤0.01% | 3526 |
|
|
2018
Q2 | $5.02M | Buy |
341,999
+89,698
| +36% | +$1.32M | ﹤0.01% | 3467 |
|
|
2018
Q1 | $3.6M | Buy |
252,301
+11,427
| +5% | +$163K | ﹤0.01% | 3482 |
|
|
2017
Q4 | $2.83M | Buy |
+240,874
| New | +$2.83M | ﹤0.01% | 3558 |
|